The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Employees With Fibromyalgia: Medical Comorbidity, Healthcare Costs, and Work Loss
Abstract
OBJECTIVES: To compare 2005 health care resources among matched samples of employees with fibromyalgia (FM), osteoarthritis (OA), and controls. METHODS: Using a claims database of privately insured individuals, FM and OA samples were derived from those with two or more disease-specific claims in 1999 to 2005 (> or =1 in 2002 to 2005). RESULTS: Total costs for employees with FM ($10,199) approached OA costs ($10,861, P = 0.3758) and were significantly higher than controls ($5274, P < 0.0001). Cost components varied across disease-specific samples (direct medical: FM $7286 vs OA $8325, P < 0.0287; pharmacy: FM $1630 vs OA $1341; indirect: FM $2913 vs OA $2537, P < 0.0001). Employees with FM had more claims than OA for psychiatric diagnoses, chronic fatigue, and most pain conditions. Use of multiple prescription drug classes was common in both samples. CONCLUSIONS: FM imposes significant economic burden. Work loss contributes substantially to the impact.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with fibromyalgia were found to miss more days of work than their colleagues without fibromyalgia.8,9”
From Does work have to be so painful? A review of the literature examining the effects of fibromyalgia on the working experience from the patient perspective (2020) · cites this paper as [9]
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
The prevalence and characteristics of fibromyalgia in the general population
Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. E. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380104 · Cited by 2,425
Lost productive time and cost due to common pain conditions in the US workforce
Stewart, W. F. (2003) · JAMA · doi:10.1001/jama.290.18.2443 · Cited by 1,570
Oliveria, S. A., Felson, D. T., Reed, J. I., Cirillo, P. A., & Walker, A. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380817 · Cited by 902
Management of fibromyalgia syndrome
Goldenberg, D. L. (2004) · JAMA · doi:10.1001/jama.292.19.2388 · Cited by 850
Mease, P. J. (2005) · PubMed · Cited by 528
A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia
Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L., Russell, I. J., & Yunus, M. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400904 · Cited by 377
Characteristics and healthcare costs of patients with fibromyalgia syndrome
Berger, A., Dukes, E. M., Martin, S. A., Edelsberg, J., & Oster, G. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01480.x · Cited by 338
The Incidence of Fibromyalgia and Its Associated Comorbidities
Weir, P. T., Harlan, G. A., Nkoy, F. L., Jones, S. S., Hegmann, K. T., Gren, L. H., & Lyon, J. L. (2006) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000221817.46231.18 · Cited by 320
Classification, epidemiology, and natural history of fibromyalgia
White, K. P., & Harth, M. (2001) · Current Pain and Headache Reports · doi:10.1007/s11916-001-0021-2 · Cited by 246
Psychosocial Factors in Fibromyalgia Compared With Rheumatoid Arthritis
Walker, E. A., Keegan, D. A., Gardner, G. C., Sullivan, M., Katon, W. J., & Bernstein, D. P. (1997) · Psychosomatic Medicine · doi:10.1097/00006842-199711000-00002 · Cited by 204
Work and disability status of persons with fibromyalgia.
Wolfe, F., Anderson, J. J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L., Russell, I. J., & Yunus, M. B. (1997) · PubMed · Cited by 181
Economic cost and epidemiological characteristics of patients with fibromyalgia claims.
Robinson, R. L., Birnbaum, H. G., Morley, M. A., Sisitsky, T., Greenberg, P. E., & Claxton, A. J. (2003) · PubMed · Cited by 155
Self-citationThe Genetics of Fibromyalgia Syndrome
Buskila, D., Sarzi‐Puttini, P., & Ablin, J. N. (2006) · Pharmacogenomics · doi:10.2217/14622416.8.1.67 · Cited by 146
Biology and therapy of fibromyalgia. New therapies in fibromyalgia.
Arnold (2006) · Arthritis Research & Therapy · doi:10.1186/ar1971 · Cited by 145
Health services costs and their determinants in women with fibromyalgia.
Penrod, J. R., Bernatsky, S., Adam, V., Baron, M. G., Dayan, N., & Dobkin, P. L. (2004) · PubMed · Cited by 133
White, K. P., Speechley, M. R., Harth, M., & Østbye, T. (1999) · PubMed · Cited by 115
Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain
Goldenberg, D. L. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.02.012 · Cited by 99
Pharmacological strategies for the prevention of Alzheimer’s disease
Doraiswamy, P. M., & Xiong, G. L. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.1.1 · Cited by 96
Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently.
Robinson, R. L., Birnbaum, H. G., Morley, M. A., Sisitsky, T., Greenberg, P. E., & Wolfe, F. (2004) · PubMed · Cited by 67
Self-citationEpidemiology and Social Costs of Low Back Pain and Fibromyalgia
de Girolamo, G. (1991) · Clinical Journal of Pain · doi:10.1097/00002508-199103001-00002 · Cited by 59
Chapman, S. L., & Brena, S. F. (1985) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm0703_5 · Cited by 50
In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review
Robinson, R. L., & Jones, M. L. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1027 · Cited by 46
Self-citationEconomic Burden of Illness for Employees with Painful Conditions
White, A. G., Birnbaum, H. G., Mareva, M. N., Henckler, A., Grossman, P., & Mallett, D. A. (2005) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000172867.29041.eb · Cited by 37
Self-citationFibromyalgia: the nerve of that disease.
Levine, J. D., & Reichling, D. B. (2005) · PubMed · Cited by 18
Atsumi (2000) · doi:10.1002/1529-0131(200009)43:9
Flagged first, then by citations
Cited by
Sorted by citations
Manchikanti, L. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s5 · Cited by 430
Socio-economic costs of osteoarthritis: A systematic review of cost-of-illness studies
Puig‐Junoy, J., & Zamora, A. R. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.10.012 · Cited by 248
Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies
Xie, F., Kovic, B., Jin, X., He, X., Wang, M., & Silvestre, C. (2016) · PharmacoEconomics · doi:10.1007/s40273-016-0424-x · Cited by 203
Schaefer, C. P., Chandran, A., Hufstader, M. A., Baik, R., McNett, M., Goldenberg, D. L., Gerwin, R. D., & Zlateva, G. (2011) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-9-71 · Cited by 159
Clinical manifestations and diagnosis of fibromyalgia
Bennett, R. M. (2009) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.05.009 · Cited by 138
Metadata
- Authors
- White, L. A., Birnbaum, H. G., Kaltenboeck, A., Tang, J., Mallett, D., & Robinson, R. L.
- Affiliations
- Analysis Group (United States) (US)
- Eli Lilly (United States) (US)
- Corresponding author
- White, Leigh Ann
- Venue
- Journal of Occupational & Environmental Medicine
- Published
- 2008-01
- Volume
- 50
- Issue
- 1
- Pages
- 13-24
- ISSN
- 1076-2752 (ISSN-L)
- OpenAlex
- W2090137489
- Cited by
- 168
- References
- 27
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 2 · 2022: 10 · 2021: 6 · 2020: 5 · 2019: 3 · 2018: 5 · 2017: 11 · 2016: 11 · 2015: 14 · 2014: 10 · 2013: 7 · 2012: 15
- FWCI
- 14.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Occupational and Environmental Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- fibromyalgia, osteoarthritis, health care costs, comorbidities, work loss, economic burden, prescription drug use, psychiatric comorbidity, chronic fatigue, pain conditions
- MeSH terms
- Absenteeism, Drug Utilization, Employment, Female, Fibromyalgia, Health Services, Humans, Male, Middle Aged, Osteoarthritis, United States, Comorbidity, Prevalence, Case-Control Studies, Health Care Costs, Employer Health Costs, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
